[
  {
    "ts": null,
    "headline": "CRISPR Therapeutics: An Uninspiring Start For Casgevy",
    "summary": "CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious \"Hold\" within a barbell portfolio.",
    "url": "https://finnhub.io/api/news?id=774ffbfb9ba9f0ea1819e4599c214d421107e388e57de809a7ebbbf22c59949c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741898461,
      "headline": "CRISPR Therapeutics: An Uninspiring Start For Casgevy",
      "id": 133165247,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/113456532/image_113456532.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious \"Hold\" within a barbell portfolio.",
      "url": "https://finnhub.io/api/news?id=774ffbfb9ba9f0ea1819e4599c214d421107e388e57de809a7ebbbf22c59949c"
    }
  },
  {
    "ts": null,
    "headline": "Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds",
    "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
    "url": "https://finnhub.io/api/news?id=6244ef2070ffec6510ac57ae72f45801055ea7e4b87544dc9c976b6f4d5cc7a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741885676,
      "headline": "Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds",
      "id": 133185353,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
      "url": "https://finnhub.io/api/news?id=6244ef2070ffec6510ac57ae72f45801055ea7e4b87544dc9c976b6f4d5cc7a4"
    }
  },
  {
    "ts": null,
    "headline": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
    "summary": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=525462baf97cedb30694019df10579d06c99d166a081e7f12a22589e2e566f2e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741880408,
      "headline": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
      "id": 133185354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "GILD vs. VRTX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=525462baf97cedb30694019df10579d06c99d166a081e7f12a22589e2e566f2e"
    }
  },
  {
    "ts": null,
    "headline": "Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?",
    "summary": "Gilead (GILD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=f4f5ba28378e34cb23139f6521ee9a428121df1b6b9767a0c58b1f15fb53e3d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741879829,
      "headline": "Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?",
      "id": 133185355,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=f4f5ba28378e34cb23139f6521ee9a428121df1b6b9767a0c58b1f15fb53e3d4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=80375b804cb141999b51d7adc2cc24a64d0f8d5aa714c4b5c8349fdf1d86abd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741870813,
      "headline": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 133185356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=80375b804cb141999b51d7adc2cc24a64d0f8d5aa714c4b5c8349fdf1d86abd9"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More",
    "summary": "TSVT and PTGX are in the spotlight this week following an acquisition agreement and study data, respectively.",
    "url": "https://finnhub.io/api/news?id=6519bab17e273ef85c89ff51b950111014b85fc5e1c47175413fe535cb4ddaca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741870680,
      "headline": "Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More",
      "id": 133185357,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "TSVT and PTGX are in the spotlight this week following an acquisition agreement and study data, respectively.",
      "url": "https://finnhub.io/api/news?id=6519bab17e273ef85c89ff51b950111014b85fc5e1c47175413fe535cb4ddaca"
    }
  }
]